Week in review: Nanoparticles prevent graft rejection, COVID-19 and retinal vessels, genetics and glaucoma

Nanoparticles added to injections may prevent corneal graft rejection, the retinal microvasculature is affected by COVID-19 infection, and increased genetic risk of glaucoma accelerates visual field loss.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553